The U.S. Food and Drug Administration will hold a discussion session with dairy industry officials regarding dairy drug residue sampling options. The session is set for March 24, 10 a.m. to 2 p.m., in Sacramento, Calif.
FDA sent discussion session invitations to milk regulatory agencies and industry organizations in neighboring westem states. Meeting room space is limited, and location was not specified.
FDA is attempting to determine if there is a correlation between illegal drug residues found in meat tissue samples from some culled dairy cows and the milk supply from those farms. The agency is seeking practical recommendations to replace a testing plan introduced previously, but subsequently postponed due to controversy among dairy producer and industry organizations.